enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. List of withdrawn drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_withdrawn_drugs

   Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [ 4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [ 3][ 5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [ 2] Reintroduced 2002 with restricted indication and ...

3. Strontium ranelate - Wikipedia

   en.wikipedia.org/wiki/Strontium_ranelate

   Servier states that the use is now restricted to treatment of severe osteoporosis in postmenopausal women at high risk for fracture. [2] The European Pharmacovigilance Risk Assessment Committee (PRAC) recommended restriction in the use of strontium ranelate, based on a routine benefit-risk assessment of the medicine, which included data showing ...

4. Bisphosphonate - Wikipedia

   en.wikipedia.org/wiki/Bisphosphonate

   Bisphosphonates are used to treat osteoporosis, osteitis deformans (Paget's disease of the bone), bone metastasis (with or without hypercalcemia), multiple myeloma, and other conditions involving fragile, breakable bone. In osteoporosis and Paget's, the most popular first-line bisphosphonate drugs are alendronate and risedronate.

5. FDA warns Boniva, Fosamax and other osteoporosis drugs ... - AOL

   www.aol.com/news/2010-10-13-fda-warns-about...

   Osteoporosis drugs taken to prevent bone fracture may cause rare, but critical, fractures of their own, the Food and Drug Administration announced today in a warning to consumers. The agency also ...

6. Medicare costs significantly lowered on popular prescription ...

   www.aol.com/medicare-costs-significantly-lowered...

   Here is the list of drugs, the condition they treat, the 2026 pricing for a 30-day supply of each drug, and the discount off the list price: Eliquis Conditions: Prevention and treatment of blood clots

7. Medication-related osteonecrosis of the jaw - Wikipedia

   en.wikipedia.org/wiki/Medication-related_osteo...

   Frequency. 0.2% for those on biphosphonate type drugs >4 years. Medication-related osteonecrosis of the jaw ( MON, MRONJ) is progressive death of the jawbone in a person exposed to a medication known to increase the risk of disease, in the absence of a previous radiation treatment.